These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 20371728)
1. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells. Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728 [TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905 [TBL] [Abstract][Full Text] [Related]
3. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells. Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873 [TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells. Suyama H; Igishi T; Ueda Y; Shigeoka Y; Kodani M; Morita M; Takeda K; Sumikawa T; Nakazaki H; Matsunami K; Matsumoto S; Shimizu E Oncol Rep; 2010 Jan; 23(1):217-22. PubMed ID: 19956885 [TBL] [Abstract][Full Text] [Related]
5. SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation. Xu Y; Fang F; St Clair DK; Sompol P; Josson S; St Clair WH Mol Cancer Ther; 2008 Aug; 7(8):2367-76. PubMed ID: 18723484 [TBL] [Abstract][Full Text] [Related]
6. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. Huang DY; Chao Y; Tai MH; Yu YH; Lin WW J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553 [TBL] [Abstract][Full Text] [Related]
7. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539 [TBL] [Abstract][Full Text] [Related]
8. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
9. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Xu Y; Josson S; Fang F; Oberley TD; St Clair DK; Wan XS; Sun Y; Bakthavatchalu V; Muthuswamy A; St Clair WH Cancer Res; 2009 Apr; 69(8):3267-71. PubMed ID: 19351823 [TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010 [TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
12. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells. Xu Y; Fang F; St Clair DK; Josson S; Sompol P; Spasojevic I; St Clair WH Mol Cancer Ther; 2007 Jul; 6(7):2048-56. PubMed ID: 17604335 [TBL] [Abstract][Full Text] [Related]
13. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro]. Ma L; Shen YY; Zhou P; Zhou J; Guo F Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967 [TBL] [Abstract][Full Text] [Related]
14. Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines. Guo F; Kang S; Zhou P; Guo L; Ma L; Hou J Mol Immunol; 2011 Oct; 49(1-2):8-17. PubMed ID: 21856005 [TBL] [Abstract][Full Text] [Related]
15. RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells. Wei X; Xu Y; Xu FF; Chaiswing L; Schnell D; Noel T; Wang C; Chen J; St Clair DK; St Clair WH Cancer Res; 2017 Mar; 77(6):1345-1356. PubMed ID: 28108513 [TBL] [Abstract][Full Text] [Related]
17. Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival. Yao JE; Yan M; Guan Z; Pan CB; Xia LP; Li CX; Wang LH; Long ZJ; Zhao Y; Li MW; Zheng FM; Xu J; Lin DJ; Liu Q Mol Cancer; 2009 Nov; 8():95. PubMed ID: 19891769 [TBL] [Abstract][Full Text] [Related]
18. Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen‑independent prostate cancer cells. Zhu HC; Qiu T; Dan C; Liu XH; Hu CH Mol Med Rep; 2015 Feb; 11(2):1167-73. PubMed ID: 25370388 [TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells. Parmar S; Smith J; Sassano A; Uddin S; Katsoulidis E; Majchrzak B; Kambhampati S; Eklund EA; Tallman MS; Fish EN; Platanias LC Blood; 2005 Oct; 106(7):2436-43. PubMed ID: 15790787 [TBL] [Abstract][Full Text] [Related]
20. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Sun Y; St Clair DK; Fang F; Warren GW; Rangnekar VM; Crooks PA; St Clair WH Mol Cancer Ther; 2007 Sep; 6(9):2477-86. PubMed ID: 17876045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]